Resilience is your biomanufacturing innovation partner, leading the pursuit of novel medicines by revolutionizing how they’re made, funded and scaled.
Driving Innovative Biomanufacturing
SOLUTIONS Custom-Fit to Your Needs
Resilience is a technology company dedicated to broadening access to complex medicines and to protecting biopharmaceutical supply chains against disruption. We’re building a sustainable network of high-tech, end-to-end manufacturing solutions to help ensure the medicines of today and tomorrow can be made quickly, safely and at scale.
Conventional and evolved platforms engineered to help you capitalize on the potential of your recombinant protein and monoclonal antibody (mAb) discoveries
Live viruses, viral vectors and other components (including infectivity and potency assays) to enable more efficient, effective vaccine development
Process and analytical development for viral vector productions and next-generation testing methods to take your innovation from starting material to product release
Modular manufacturing processes designed to leverage the most promising emerging technologies for blood and bone marrow-centered therapies
A powerful mRNA platform, integrated supply chain and solid-state chemistry capabilities to provide a more direct, holistic path forward from first concept
THE BENEFITS OF WORKING WITH RESILIENCE
When you embark on a partnership with Resilience, you get the kind of thinking – backed by the kind of resources necessary – to future-proof the next stages of your discovery.
We do that by delivering three crucial advantages to your team:
Aligned incentives to accelerate development and to provide the investment, know-how and experience you need to optimize opportunities
Access to best-in-class development platforms derived from breakthroughs across five key modalities
A digital-first enterprise committed to delivering on the promise of cloud-based systems, advanced AI, and next-level visibility and data security